{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:29:12Z","timestamp":1765499352260,"version":"3.48.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jdcr.2025.06.046","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:23:50Z","timestamp":1753226630000},"page":"141-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Incidental treatment of granulomatosis with polyangiitis with a Janus Kinase inhibitor in a patient undergoing alopecia treatment"],"prefix":"10.1016","volume":"64","author":[{"given":"Daniela","family":"Mendez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma","family":"Bergfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2025.06.046_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112155","article-title":"Janus kinases (JAKs): the efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders","volume":"192","author":"Xu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jdcr.2025.06.046_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106362","article-title":"Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders","volume":"183","author":"Roskoski","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdcr.2025.06.046_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1075192","article-title":"Molecular dissection of Janus kinases as drug targets for inflammatory diseases","volume":"13","author":"Kwon","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jdcr.2025.06.046_bib4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/annrheumdis-2021-220484","article-title":"Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study","volume":"80","author":"Liu","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.jdcr.2025.06.046_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3899\/jrheum.221219","article-title":"Response to treatment with tofacitinib in 11 patients with refractory granulomatosis with polyangiitis","volume":"50","author":"Linde","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jdcr.2025.06.046_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1187584","article-title":"Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden","volume":"14","author":"Eriksson","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.06.046_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10067-021-05973-4","article-title":"A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis","volume":"41","author":"Rathore","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jdcr.2025.06.046_bib8","article-title":"Tofacitinib treatment of refractory cutaneous leukocytoclastic vasculitis: a case report","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.06.046_bib9","article-title":"Tofacitinib as monotherapy in cutaneous polyarteritis nodosa: a case series","volume":"7","author":"Roy","year":"2023","journal-title":"Rheumatol Adv Pract"},{"issue":"11","key":"10.1016\/j.jdcr.2025.06.046_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s40264-023-01333-0","article-title":"Managing cardiovascular and cancer risk associated with JAK inhibitors","volume":"46","author":"Yang","year":"2023","journal-title":"Drug Saf"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:24:17Z","timestamp":1765499057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625003340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":10,"alternative-id":["S2352512625003340"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.06.046","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidental treatment of granulomatosis with polyangiitis with a Janus Kinase inhibitor in a patient undergoing alopecia treatment","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}